Pleurostomophora ochracea, a Novel Agent of Human Eumycetoma with Yellow Grains
- 1 September 2012
- journal article
- case report
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 50 (9) , 2987-2994
- https://doi.org/10.1128/jcm.01470-12
Abstract
The first yellow-grain fungal mycetoma, in a 60-year-old man from Central Sudan, is reported. Morphological and phylogenetic analysis of the ribosomal small subunit (SSU), large subunit (LSU), internal transcribed spacer (ITS), β-tubulin (BT2), actin (ACT1), and elongation factor (TEF1) genes revealed that the isolate deviated from any known agent of mycetoma; it clustered in the genus Pleurostoma (anamorph genus, Pleurostomophora) in the order Calosphaeriales. The novel species, here named Pleurostomophora ochracea, is characterized by phenotypic features. The species proved to be highly susceptible to itraconazole, ketoconazole, posaconazole, and voriconazole, but not to fluconazole. The fungus was inhibited by caspofungin at 8 μg/ml, while no inhibition was found with 5-flucytosine (MIC > 64 μg/ml). Compared to other members of the genus Pleurostomophora, P. ochracea is slow growing, with a relatively high optimum growth temperature (36 to 37°C). This is the first case of a yellow-grain fungal mycetoma; yellow grains are otherwise of bacterial nature. Our case emphasizes that identification of mycetoma agents by the color of the grain only is not sufficient and may lead to inappropriate therapy.Keywords
This publication has 44 references indexed in Scilit:
- MEGA5: Molecular Evolutionary Genetics Analysis Using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony MethodsMolecular Biology and Evolution, 2011
- Chromoblastomycosis Caused byPhialophora richardsiaeAnnals of Dermatology, 2010
- Management of mycetoma: major challenge in tropical mycoses with limited international recognitionCurrent Opinion in Infectious Diseases, 2007
- In Vitro Susceptibilities of Madurella mycetomatis to Itraconazole and Amphotericin B Assessed by a Modified NCCLS Method and a Viability-Based 2,3-Bis(2-Methoxy-4-Nitro-5- Sulfophenyl)-5-[(Phenylamino)Carbonyl]-2 H - Tetrazolium Hydroxide (XTT) AssayAntimicrobial Agents and Chemotherapy, 2004
- Phylogeny and typification of Madurella mycetomatis, with a comparison of other agents of eumycetomaMycoses, 2004
- Environmental Occurrence ofMadurella mycetomatis, the Major Agent of Human Eumycetoma in SudanJournal of Clinical Microbiology, 2002
- MycetomaBritish Journal of Surgery, 1992
- Phaeohyphomycosis caused by Phialophora richardsiaeJournal of the American Academy of Dermatology, 1988
- Notes on the CalosphaerialesMycologia, 1985
- The Ascomycete ConnectionMycologia, 1983